The history of the erectile dysfunction drug presents a complex picture for shareholders. While the initial introduction generated substantial returns, the expiration of its intellectual property protection opened the https://bookmarkoffire.com/story21543145/the-copyright-and-the-pharmaceutical-industry-a-risky-opportunity